Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

March 31, 2005

Conditions

Child Development Disorders, Pervasive

Interventions

DRUG

Risperidone

Trial Locations (4)

Duke University Medical Center, Durham

Cincinnati Children's Hospital Medical Center, Cincinnati

Children's Hospital of Michigan/Wayne State University, Detroit

The Ohio State University Medical Center, Columbus

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT00166595 - Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD) | Biotech Hunter | Biotech Hunter